Table 1.
Drug | Manufacturer | Trials |
---|---|---|
BMS-833923 | Bristol–Myers Squibb | CML (NCT01218477) |
Glasdegib (PF-04449913) | Pfizer | MDS (NCT01842646) |
LEQ506 | Novartis | Solid tumors, medulloblastoma, and aBCC (NCT01106508) |
LDE255 | Novartis | MDS (NCT02323139) |
Abbreviations: CML, chronic myelogenous leukemia; MDS, myelodysplastic syndrome; aBCC, advanced basal cell carcinoma.